Karl Storz Ventures

Karl Storz Ventures is the strategic venture entity of Karl Storz, the privately held German endoscopy company headquartered in Tuttlingen. The arm backs breakthrough endoscopic and advanced surgical visualization technologies, mirroring the parent’s century-long focus on minimally invasive surgery and rigid and flexible endoscopy. Founders working on imaging chips, surgical optics, fluorescence and multispectral imaging, surgical robotics adjacencies, computer vision for the OR, and integrated OR systems fit the thesis. The parent’s family-ownership and engineering culture often translates into long horizons and patient capital relative to financial-only investors.

The fund invests at Seed and Series A with check sizes of $1M to $5M. It is headquartered in Germany, which can be advantageous for European medtech founders seeking a strategic partner with local presence and global reach. It focuses on medical devices and MedTech, with no stated AI focus, though many surgical visualization advances now depend on computational imaging.

Founders should approach with a clear thesis on how their technology integrates with or augments endoscopic and surgical visualization workflows. Demonstrable surgeon engagement, a regulatory plan for CE Mark and FDA, and openness to a co-development relationship with Karl Storz strengthen positioning. Limited public information is available about specific partners and portfolio composition, so introductions through European surgical KOLs or Karl Storz business development are the most effective paths.